J Yeungnam Med Sci.  2022 Jan;39(1):46-52. 10.12701/yujm.2021.01221.

Increase in blood glucose level and incidence of diabetic ketoacidosis in children with type 1 diabetes mellitus in the Daegu-Gyeongbuk area during the coronavirus disease 2019 (COVID-19) pandemic: a retrospective cross-sectional study

• Lee MS
• Lee R
• Ko CW
• Moon JE

• KMID: 2525027
• DOI: http://doi.org/10.12701/yujm.2021.01221

Abstract

Background
The coronavirus disease 2019 (COVID-19) outbreak in the Daegu-Gyeongbuk area in 2020 has caused difficulties in the daily life and hospital care of children with type 1 diabetes mellitus (T1DM). We detected an increase in blood sugar levels in these children and the number of patients hospitalized with more severe diabetic ketoacidosis (DKA) compared to those before COVID-19.
Methods
This single-center study was conducted at Kyungpook National University Children’s Hospital. The following patient groups were included; 45 returning patients diagnosed with T1DM and undergoing insulin treatment for more than 2 years and 20 patients newly diagnosed with T1DM before and after COVID-19 were selected by age matching. Returning patients before and after the outbreak were selected, and changes in hemoglobin A1c (HbA1c) levels were retrospectively reviewed. The HbA1c levels and severity of symptoms in newly diagnosed patients during hospitalization were examined.
Results
HbA1c levels in returning patients with T1DM were significantly increased after COVID-19 (before, 7.70%±1.38% vs. after, 8.30%±2.05%; p=0.012). There were 10 and 10 newly diagnosed patients before and after COVID-19, respectively. The proportion of patients with drowsiness and dyspnea at the time of admission was higher after COVID-19 than before (before, 2 of 10 vs. after, 4 of 10). The HbA1c levels were higher in newly diagnosed patients hospitalized after COVID-19 than before (before, 11.15% vs. after, 13.60%; p=0.036).
Conclusion
Due to COVID-19 in the Daegu-Gyeongbuk area, there was an increase in blood glucose levels in children with T1DM and in the incidence of severe DKA in newly diagnosed diabetes mellitus patients.

Keyword

Coronavirus disease 2019; COVID-19; Diabetic ketoacidosis; Type 1 diabetes mellitus

Figure

• 

  Fig. 1. Distribution by age of newly diagnosed type 1 diabetes mellitus patients before and after the coronavirus disease 2019 (COVID-19) outbreak. Non-diabetic ketoacidosis (DKA) patients were not indicated, and DKA patients were indicated according to severity.

• 

  Fig. 2. Comparison of ratio of diabetic ketoacidosis (DKA) and DKA severity in newly diagnosed type 1 diabetes mellitus patients hospitalized before and after the coronavirus disease 2019 (COVID-19) outbreak.

Reference

References

1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020; 92:401–2.

2. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91:264–6.

3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497–506.

4. World Health Organization (WHO). Timeline: WHO’s COVID-19 response [Internet]. Geneva: WHO;2020. [cited 2020 Sep 21]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!.

5. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020; 35:e61.

6. Kim JH, An JA, Min P, Bitton A, Gawande AA. How South Korea responded to the Covid-19 outbreak in Daegu. NEJM Catal Innov Care Deliv. 2020; 1(4):10.1056/CAT.20.0159.

7. Lee JY, Hong SW, Hyun M, Park JS, Lee JH, Suh YS, et al. Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea. Int J Infect Dis. 2020; 98:462–6.

8. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475–81.

9. Zhou J, Tan J. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China. Metabolism. 2020; 107:154216.

10. Kim MK, Jeon JH, Kim SW, Moon JS, Cho NH, Han E, et al. The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea. Diabetes Metab J. 2020; 44:602–13.

11. Cardona-Hernandez R, Cherubini V, Iafusco D, Schiaffini R, Luo X, Maahs DM. Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr Diabetes. 2021; 22:202–6.

12. International Society for Pediatric and Adolescent Diabetes (ISPAD). Coronavirus infection (COVID-19)-II ISPAD summary [Internet]. Berlin: ISPAD;2020. [cited 2020 Sep 26]. https://www.ispad.org/page/CoronavirusinfectionCOVID-19-IIISPADSummary.

13. Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018; 19(Suppl 27):155–77.

14. Fonseca VA, Smith H, Kuhadiya N, Leger SM, Yau CL, Reynolds K, et al. Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences. Diabetes Care. 2009; 32:1632–8.

15. Inui A, Kitaoka H, Majima M, Takamiya S, Uemoto M, Yonenaga C, et al. Effect of the Kobe earthquake on stress and glycemic control in patients with diabetes mellitus. Arch Intern Med. 1998; 158:274–8.

16. Kirizuka K, Nishizaki H, Kohriyama K, Nukata O, Arioka Y, Motobuchi M, et al. Influences of The Great Hanshin-Awaji Earthquake on glycemic control in diabetic patients. Diabetes Res Clin Pract. 1997; 36:193–6.

17. Sengül A, Ozer E, Salman S, Salman F, Sağlam Z, Sargin M, et al. Lessons learnt from influences of the Marmara earthquake on glycemic control and quality of life in people with type 1 diabetes. Endocr J. 2004; 51:407–14.

18. Nishikawa Y, Fukuda Y, Tsubokura M, Kato S, Nomura S, Saito Y. Managing type 2 diabetes mellitus through periodical hospital visits in the aftermath of the Great East Japan Earthquake disaster: a retrospective case series. PLoS One. 2015; 10:e0125632.

19. Ghosal S, Sinha B, Majumder M, Misra A. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a simulation model using multivariate regression analysis. Diabetes Metab Syndr. 2020; 14:319–23.

20. Wang G, Zhang Y, Zhao J, Zhang J, Jiang F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. Lancet. 2020; 395:945–7.

21. Brazendale K, Beets MW, Weaver RG, Pate RR, Turner-McGrievy GM, Kaczynski AT, et al. Understanding differences between summer vs. school obesogenic behaviors of children: the structured days hypothesis. Int J Behav Nutr Phys Act. 2017; 14:100.

22. Wang G, Zhang J, Lam SP, Li SX, Jiang Y, Sun W, et al. Ten-year secular trends in sleep/wake patterns in Shanghai and Hong Kong school-aged children: a tale of two cities. J Clin Sleep Med. 2019; 15:1495–502.

23. MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014; 15:175–89.

24. Nansel TR, Lipsky LM, Liu A. Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes. Am J Clin Nutr. 2016; 104:81–7.

25. Verma A, Rajput R, Verma S, Balania VK, Jangra B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 diabetes mellitus. Diabetes Metab Syndr. 2020; 14:1213–6.

26. Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020; 43:2870–2.

27. Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA. 2020; 324:801–4.

28. Korean Ministry of Education. 2019 Student health test sample statistics results [Internet]. Sejong, KR: Korean Ministry of Education;2019. [cited 2020 Sep 22]. https://www.moe.go.kr/boardCnts/view.do?boardID=294&lev=0&statusYN=W&s=moe&m=0204&opType=N&boardSeq=81310.

29. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009; 124:e1171–9.

30. Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity. Diabetes Technol Ther. 2020; 22:462–7.